Products Categories
CAS No.: | 85-79-0 |
---|---|
Name: | Cinchocaine |
Article Data: | 11 |
Molecular Structure: | |
Formula: | C20H29N3O2 |
Molecular Weight: | 343.469 |
Synonyms: | Cinchocaine(Dibucaine);Cinchoninamide,2-butoxy-N-[2-(diethylamino)ethyl]- (8CI);2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide;Dermacaine;Dibucaine;Dibucaine base;N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide;NSC 159055;Nupercainal;Percamine; |
EINECS: | 201-632-1 |
Density: | 1.071 g/cm3 |
Melting Point: | -51 °C |
Boiling Point: | 496.3 °C at 760 mmHg |
Flash Point: | 254 °C |
Solubility: | 68.01mg/L(temperature not stated) |
Hazard Symbols: | Xi |
Risk Codes: | 22-41 |
Safety: | 26-39 |
PSA: | 54.46000 |
LogP: | 3.87620 |
The Dibucaine is an organic compound with the formula C20H29N3O2. The IUPAC name of this chemical is 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide. With the CAS registry number 85-79-0, it is also named as 4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-. The product's categories are DIA - DICDrugs of Abuse; Alphabetic; Chemical Structure; D; Others. Besides, it can be used in organic synthesis.
Physical properties about Dibucaine are: (1)ACD/LogP: 3.08; (2)ACD/LogD (pH 5.5): 0.03; (3)ACD/LogD (pH 7.4): 0.93; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 7.88; (8)#H bond acceptors: 5; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 10; (11)Polar Surface Area: 45.67 Å2; (12)Index of Refraction: 1.557; (13)Molar Refractivity: 103.27 cm3; (14)Molar Volume: 320.4 cm3; (15)Polarizability: 40.94×10-24cm3; (16)Surface Tension: 42.6 dyne/cm; (17)Density: 1.071 g/cm3; (18)Flash Point: 254 °C; (19)Enthalpy of Vaporization: 76.41 kJ/mol; (20)Boiling Point: 496.3 °C at 760 mmHg; (21)Vapour Pressure: 5.46E-10 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
It is harmful if swallowed. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Besides, this chemical is risk of serious damage to eyes. When you are using it, wear eye/face protection.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(c1c2ccccc2nc(OCCCC)c1)NCCN(CC)CC
(2)InChI: InChI=1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
(3)InChIKey: PUFQVTATUTYEAL-UHFFFAOYAU
(4)Std. InChI: InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
(5)Std. InChIKey: PUFQVTATUTYEAL-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | LDLo | oral | 50mg/kg (50mg/kg) | "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 209, 1969. | |
frog | LDLo | intraspinal | 4mg/kg (4mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 45, Pg. 291, 1932. | |
guinea pig | LDLo | subcutaneous | 112mg/kg (112mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
mouse | LD50 | intraperitoneal | 24500ug/kg (24.5mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 925, 1960. | |
mouse | LD50 | subcutaneous | 28500ug/kg (28.5mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 925, 1960. | |
mouse | LDLo | intravenous | 6mg/kg (6mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 4, 1950. | |
rabbit | LD50 | intravenous | 2500ug/kg (2.5mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Proceedings of the Society for Experimental Biology and Medicine. Vol. 29, Pg. 368, 1932. |
rabbit | LD50 | subcutaneous | 8500ug/kg (8.5mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Proceedings of the Society for Experimental Biology and Medicine. Vol. 29, Pg. 368, 1932. |
rabbit | LDLo | intraspinal | 2100ug/kg (2.1mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 54, Pg. 137, 1935. | |
rat | LDLo | intraperitoneal | 7mg/kg (7mg/kg) | Toxicology and Applied Pharmacology. Vol. 1, Pg. 156, 1959. |